nodes	percent_of_prediction	percent_of_DWPC	metapath
Boceprevir—ABCB1—colon cancer	0.442	1	CbGaD
Boceprevir—CYP3A5—Irinotecan—colon cancer	0.043	0.24	CbGbCtD
Boceprevir—CYP3A5—Vincristine—colon cancer	0.0376	0.21	CbGbCtD
Boceprevir—ABCB1—Irinotecan—colon cancer	0.028	0.156	CbGbCtD
Boceprevir—ABCB1—Vincristine—colon cancer	0.0245	0.136	CbGbCtD
Boceprevir—CYP3A4—Irinotecan—colon cancer	0.0168	0.0935	CbGbCtD
Boceprevir—ABCB1—Methotrexate—colon cancer	0.0148	0.0826	CbGbCtD
Boceprevir—CYP3A4—Vincristine—colon cancer	0.0147	0.0817	CbGbCtD
Boceprevir—CMA1—blood vessel—colon cancer	0.00984	0.075	CbGeAlD
Boceprevir—CTSK—gall bladder—colon cancer	0.00596	0.0455	CbGeAlD
Boceprevir—CTSS—gall bladder—colon cancer	0.00523	0.0398	CbGeAlD
Boceprevir—CTSL—embryo—colon cancer	0.00502	0.0382	CbGeAlD
Boceprevir—CTSV—renal system—colon cancer	0.00465	0.0354	CbGeAlD
Boceprevir—CMA1—smooth muscle tissue—colon cancer	0.00461	0.0352	CbGeAlD
Boceprevir—CTSL—epithelium—colon cancer	0.0041	0.0312	CbGeAlD
Boceprevir—CTSL—smooth muscle tissue—colon cancer	0.00395	0.0301	CbGeAlD
Boceprevir—CTSV—lymphoid tissue—colon cancer	0.00386	0.0294	CbGeAlD
Boceprevir—CTSL—renal system—colon cancer	0.0038	0.0289	CbGeAlD
Boceprevir—CMA1—lymphoid tissue—colon cancer	0.00369	0.0281	CbGeAlD
Boceprevir—CMA1—digestive system—colon cancer	0.00364	0.0278	CbGeAlD
Boceprevir—Telaprevir—ABCB1—colon cancer	0.00344	1	CrCbGaD
Boceprevir—CTSV—vagina—colon cancer	0.00337	0.0257	CbGeAlD
Boceprevir—CMA1—bone marrow—colon cancer	0.00336	0.0256	CbGeAlD
Boceprevir—CTSS—embryo—colon cancer	0.00331	0.0252	CbGeAlD
Boceprevir—CTSL—lymphoid tissue—colon cancer	0.00315	0.024	CbGeAlD
Boceprevir—CTSL—digestive system—colon cancer	0.00312	0.0237	CbGeAlD
Boceprevir—CTSK—smooth muscle tissue—colon cancer	0.00297	0.0227	CbGeAlD
Boceprevir—CTSL—bone marrow—colon cancer	0.00287	0.0219	CbGeAlD
Boceprevir—CTSK—renal system—colon cancer	0.00286	0.0218	CbGeAlD
Boceprevir—CTSL—vagina—colon cancer	0.00275	0.021	CbGeAlD
Boceprevir—CMA1—liver—colon cancer	0.00271	0.0207	CbGeAlD
Boceprevir—CTSS—smooth muscle tissue—colon cancer	0.00261	0.0199	CbGeAlD
Boceprevir—CTSS—renal system—colon cancer	0.00251	0.0191	CbGeAlD
Boceprevir—CTSK—lymphoid tissue—colon cancer	0.00238	0.0181	CbGeAlD
Boceprevir—CTSK—digestive system—colon cancer	0.00235	0.0179	CbGeAlD
Boceprevir—CTSL—liver—colon cancer	0.00232	0.0177	CbGeAlD
Boceprevir—CTSK—bone marrow—colon cancer	0.00216	0.0165	CbGeAlD
Boceprevir—CTSS—lymphoid tissue—colon cancer	0.00208	0.0159	CbGeAlD
Boceprevir—CMA1—lymph node—colon cancer	0.00208	0.0159	CbGeAlD
Boceprevir—CTSK—vagina—colon cancer	0.00207	0.0158	CbGeAlD
Boceprevir—CTSS—digestive system—colon cancer	0.00206	0.0157	CbGeAlD
Boceprevir—CTSS—bone marrow—colon cancer	0.0019	0.0144	CbGeAlD
Boceprevir—CTSS—vagina—colon cancer	0.00182	0.0138	CbGeAlD
Boceprevir—CTSL—lymph node—colon cancer	0.00178	0.0136	CbGeAlD
Boceprevir—CTSK—liver—colon cancer	0.00175	0.0133	CbGeAlD
Boceprevir—CTSS—liver—colon cancer	0.00153	0.0117	CbGeAlD
Boceprevir—CTSK—lymph node—colon cancer	0.00134	0.0102	CbGeAlD
Boceprevir—CTSS—lymph node—colon cancer	0.00117	0.00895	CbGeAlD
Boceprevir—ABCB1—blood vessel—colon cancer	0.00098	0.00747	CbGeAlD
Boceprevir—CYP3A5—renal system—colon cancer	0.000833	0.00635	CbGeAlD
Boceprevir—CYP3A5—digestive system—colon cancer	0.000683	0.00521	CbGeAlD
Boceprevir—CYP3A4—renal system—colon cancer	0.000625	0.00476	CbGeAlD
Boceprevir—CYP3A5—vagina—colon cancer	0.000603	0.0046	CbGeAlD
Boceprevir—ABCB1—embryo—colon cancer	0.000585	0.00445	CbGeAlD
Boceprevir—CYP3A4—digestive system—colon cancer	0.000513	0.00391	CbGeAlD
Boceprevir—CYP3A5—liver—colon cancer	0.000509	0.00388	CbGeAlD
Boceprevir—ABCB1—epithelium—colon cancer	0.000477	0.00363	CbGeAlD
Boceprevir—ABCB1—renal system—colon cancer	0.000442	0.00337	CbGeAlD
Boceprevir—CYP3A4—liver—colon cancer	0.000382	0.00291	CbGeAlD
Boceprevir—ABCB1—lymphoid tissue—colon cancer	0.000367	0.0028	CbGeAlD
Boceprevir—ABCB1—digestive system—colon cancer	0.000363	0.00277	CbGeAlD
Boceprevir—ABCB1—bone marrow—colon cancer	0.000335	0.00255	CbGeAlD
Boceprevir—ABCB1—vagina—colon cancer	0.00032	0.00244	CbGeAlD
Boceprevir—Neuropathy peripheral—Capecitabine—colon cancer	0.000275	0.00141	CcSEcCtD
Boceprevir—Stomatitis—Capecitabine—colon cancer	0.000274	0.0014	CcSEcCtD
Boceprevir—Infection—Vincristine—colon cancer	0.000273	0.0014	CcSEcCtD
Boceprevir—Conjunctivitis—Capecitabine—colon cancer	0.000273	0.0014	CcSEcCtD
Boceprevir—Urinary tract infection—Capecitabine—colon cancer	0.000273	0.0014	CcSEcCtD
Boceprevir—ABCB1—liver—colon cancer	0.00027	0.00206	CbGeAlD
Boceprevir—Confusional state—Irinotecan—colon cancer	0.00027	0.00138	CcSEcCtD
Boceprevir—Nervous system disorder—Vincristine—colon cancer	0.000269	0.00138	CcSEcCtD
Boceprevir—Thrombocytopenia—Vincristine—colon cancer	0.000269	0.00138	CcSEcCtD
Boceprevir—Chest pain—Fluorouracil—colon cancer	0.000267	0.00137	CcSEcCtD
Boceprevir—Myalgia—Fluorouracil—colon cancer	0.000267	0.00137	CcSEcCtD
Boceprevir—Infection—Irinotecan—colon cancer	0.000266	0.00136	CcSEcCtD
Boceprevir—Hyperhidrosis—Vincristine—colon cancer	0.000266	0.00136	CcSEcCtD
Boceprevir—Hepatobiliary disease—Capecitabine—colon cancer	0.000266	0.00136	CcSEcCtD
Boceprevir—Epistaxis—Capecitabine—colon cancer	0.000265	0.00135	CcSEcCtD
Boceprevir—Discomfort—Fluorouracil—colon cancer	0.000264	0.00135	CcSEcCtD
Boceprevir—Shock—Irinotecan—colon cancer	0.000263	0.00135	CcSEcCtD
Boceprevir—Nervous system disorder—Irinotecan—colon cancer	0.000262	0.00134	CcSEcCtD
Boceprevir—Agranulocytosis—Capecitabine—colon cancer	0.000262	0.00134	CcSEcCtD
Boceprevir—Thrombocytopenia—Irinotecan—colon cancer	0.000262	0.00134	CcSEcCtD
Boceprevir—Irritability—Methotrexate—colon cancer	0.000259	0.00132	CcSEcCtD
Boceprevir—Hyperhidrosis—Irinotecan—colon cancer	0.000259	0.00132	CcSEcCtD
Boceprevir—Confusional state—Fluorouracil—colon cancer	0.000258	0.00132	CcSEcCtD
Boceprevir—Mood swings—Methotrexate—colon cancer	0.000257	0.00131	CcSEcCtD
Boceprevir—Hypotension—Vincristine—colon cancer	0.000257	0.00131	CcSEcCtD
Boceprevir—Infection—Fluorouracil—colon cancer	0.000255	0.0013	CcSEcCtD
Boceprevir—Rhinitis—Capecitabine—colon cancer	0.000253	0.00129	CcSEcCtD
Boceprevir—Nervous system disorder—Fluorouracil—colon cancer	0.000251	0.00129	CcSEcCtD
Boceprevir—Thrombocytopenia—Fluorouracil—colon cancer	0.000251	0.00128	CcSEcCtD
Boceprevir—Hypoaesthesia—Capecitabine—colon cancer	0.000251	0.00128	CcSEcCtD
Boceprevir—CTSV—Immune System—BCL10—colon cancer	0.000251	0.00521	CbGpPWpGaD
Boceprevir—Musculoskeletal discomfort—Vincristine—colon cancer	0.00025	0.00128	CcSEcCtD
Boceprevir—Pharyngitis—Capecitabine—colon cancer	0.00025	0.00128	CcSEcCtD
Boceprevir—Tachycardia—Fluorouracil—colon cancer	0.00025	0.00128	CcSEcCtD
Boceprevir—Hypotension—Irinotecan—colon cancer	0.00025	0.00128	CcSEcCtD
Boceprevir—Urinary tract disorder—Capecitabine—colon cancer	0.000249	0.00127	CcSEcCtD
Boceprevir—Insomnia—Vincristine—colon cancer	0.000249	0.00127	CcSEcCtD
Boceprevir—Oedema peripheral—Capecitabine—colon cancer	0.000248	0.00127	CcSEcCtD
Boceprevir—Connective tissue disorder—Capecitabine—colon cancer	0.000248	0.00127	CcSEcCtD
Boceprevir—Urethral disorder—Capecitabine—colon cancer	0.000247	0.00126	CcSEcCtD
Boceprevir—Paraesthesia—Vincristine—colon cancer	0.000247	0.00126	CcSEcCtD
Boceprevir—Breast disorder—Methotrexate—colon cancer	0.000245	0.00125	CcSEcCtD
Boceprevir—Visual impairment—Capecitabine—colon cancer	0.000243	0.00124	CcSEcCtD
Boceprevir—Insomnia—Irinotecan—colon cancer	0.000242	0.00124	CcSEcCtD
Boceprevir—Paraesthesia—Irinotecan—colon cancer	0.00024	0.00123	CcSEcCtD
Boceprevir—CYP3A4—Irinotecan Pathway—APC—colon cancer	0.00024	0.00499	CbGpPWpGaD
Boceprevir—Hypotension—Fluorouracil—colon cancer	0.000239	0.00122	CcSEcCtD
Boceprevir—Decreased appetite—Vincristine—colon cancer	0.000239	0.00122	CcSEcCtD
Boceprevir—Dyspnoea—Irinotecan—colon cancer	0.000239	0.00122	CcSEcCtD
Boceprevir—Erythema multiforme—Capecitabine—colon cancer	0.000238	0.00122	CcSEcCtD
Boceprevir—CMA1—Signaling by SCF-KIT—PIK3CA—colon cancer	0.000237	0.00493	CbGpPWpGaD
Boceprevir—Gastrointestinal disorder—Vincristine—colon cancer	0.000237	0.00121	CcSEcCtD
Boceprevir—Fatigue—Vincristine—colon cancer	0.000237	0.00121	CcSEcCtD
Boceprevir—Eye disorder—Capecitabine—colon cancer	0.000236	0.0012	CcSEcCtD
Boceprevir—Dyspepsia—Irinotecan—colon cancer	0.000236	0.0012	CcSEcCtD
Boceprevir—Tinnitus—Capecitabine—colon cancer	0.000235	0.0012	CcSEcCtD
Boceprevir—Constipation—Vincristine—colon cancer	0.000235	0.0012	CcSEcCtD
Boceprevir—Pain—Vincristine—colon cancer	0.000235	0.0012	CcSEcCtD
Boceprevir—Flushing—Capecitabine—colon cancer	0.000234	0.0012	CcSEcCtD
Boceprevir—Cardiac disorder—Capecitabine—colon cancer	0.000234	0.0012	CcSEcCtD
Boceprevir—CMA1—Signaling Pathways—AXIN2—colon cancer	0.000234	0.00486	CbGpPWpGaD
Boceprevir—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.000234	0.00119	CcSEcCtD
Boceprevir—CTSL—Extracellular matrix organization—CASP3—colon cancer	0.000233	0.00484	CbGpPWpGaD
Boceprevir—CTSV—Extracellular matrix organization—CASP3—colon cancer	0.000233	0.00484	CbGpPWpGaD
Boceprevir—Decreased appetite—Irinotecan—colon cancer	0.000233	0.00119	CcSEcCtD
Boceprevir—Eosinophilia—Methotrexate—colon cancer	0.000232	0.00119	CcSEcCtD
Boceprevir—Insomnia—Fluorouracil—colon cancer	0.000232	0.00119	CcSEcCtD
Boceprevir—Gastrointestinal disorder—Irinotecan—colon cancer	0.000231	0.00118	CcSEcCtD
Boceprevir—Fatigue—Irinotecan—colon cancer	0.000231	0.00118	CcSEcCtD
Boceprevir—Paraesthesia—Fluorouracil—colon cancer	0.00023	0.00118	CcSEcCtD
Boceprevir—Pancreatitis—Methotrexate—colon cancer	0.00023	0.00118	CcSEcCtD
Boceprevir—Pain—Irinotecan—colon cancer	0.000229	0.00117	CcSEcCtD
Boceprevir—Constipation—Irinotecan—colon cancer	0.000229	0.00117	CcSEcCtD
Boceprevir—Angiopathy—Capecitabine—colon cancer	0.000229	0.00117	CcSEcCtD
Boceprevir—Dyspnoea—Fluorouracil—colon cancer	0.000229	0.00117	CcSEcCtD
Boceprevir—Immune system disorder—Capecitabine—colon cancer	0.000228	0.00116	CcSEcCtD
Boceprevir—Mediastinal disorder—Capecitabine—colon cancer	0.000227	0.00116	CcSEcCtD
Boceprevir—CTSV—Adaptive Immune System—CD8A—colon cancer	0.000226	0.0047	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—CD8A—colon cancer	0.000226	0.0047	CbGpPWpGaD
Boceprevir—Chills—Capecitabine—colon cancer	0.000226	0.00116	CcSEcCtD
Boceprevir—Dyspepsia—Fluorouracil—colon cancer	0.000226	0.00115	CcSEcCtD
Boceprevir—Arrhythmia—Capecitabine—colon cancer	0.000225	0.00115	CcSEcCtD
Boceprevir—Abdominal discomfort—Methotrexate—colon cancer	0.000225	0.00115	CcSEcCtD
Boceprevir—Gastrointestinal pain—Vincristine—colon cancer	0.000225	0.00115	CcSEcCtD
Boceprevir—Decreased appetite—Fluorouracil—colon cancer	0.000223	0.00114	CcSEcCtD
Boceprevir—Alopecia—Capecitabine—colon cancer	0.000223	0.00114	CcSEcCtD
Boceprevir—Pancytopenia—Methotrexate—colon cancer	0.000223	0.00114	CcSEcCtD
Boceprevir—Gastrointestinal disorder—Fluorouracil—colon cancer	0.000221	0.00113	CcSEcCtD
Boceprevir—Mental disorder—Capecitabine—colon cancer	0.000221	0.00113	CcSEcCtD
Boceprevir—Feeling abnormal—Irinotecan—colon cancer	0.000221	0.00113	CcSEcCtD
Boceprevir—CMA1—Signaling by SCF-KIT—HRAS—colon cancer	0.00022	0.00456	CbGpPWpGaD
Boceprevir—Malnutrition—Capecitabine—colon cancer	0.000219	0.00112	CcSEcCtD
Boceprevir—Erythema—Capecitabine—colon cancer	0.000219	0.00112	CcSEcCtD
Boceprevir—Neutropenia—Methotrexate—colon cancer	0.000219	0.00112	CcSEcCtD
Boceprevir—Dysuria—Methotrexate—colon cancer	0.000219	0.00112	CcSEcCtD
Boceprevir—Pain—Fluorouracil—colon cancer	0.000219	0.00112	CcSEcCtD
Boceprevir—Gastrointestinal pain—Irinotecan—colon cancer	0.000219	0.00112	CcSEcCtD
Boceprevir—Body temperature increased—Vincristine—colon cancer	0.000217	0.00111	CcSEcCtD
Boceprevir—Abdominal pain—Vincristine—colon cancer	0.000217	0.00111	CcSEcCtD
Boceprevir—CMA1—Extracellular matrix organization—CASP3—colon cancer	0.000217	0.0045	CbGpPWpGaD
Boceprevir—Flatulence—Capecitabine—colon cancer	0.000216	0.00111	CcSEcCtD
Boceprevir—Erectile dysfunction—Methotrexate—colon cancer	0.000216	0.0011	CcSEcCtD
Boceprevir—Dysgeusia—Capecitabine—colon cancer	0.000215	0.0011	CcSEcCtD
Boceprevir—Photosensitivity reaction—Methotrexate—colon cancer	0.000214	0.00109	CcSEcCtD
Boceprevir—Back pain—Capecitabine—colon cancer	0.000212	0.00109	CcSEcCtD
Boceprevir—Body temperature increased—Irinotecan—colon cancer	0.000212	0.00108	CcSEcCtD
Boceprevir—Abdominal pain—Irinotecan—colon cancer	0.000212	0.00108	CcSEcCtD
Boceprevir—Feeling abnormal—Fluorouracil—colon cancer	0.000211	0.00108	CcSEcCtD
Boceprevir—Muscle spasms—Capecitabine—colon cancer	0.000211	0.00108	CcSEcCtD
Boceprevir—Pneumonia—Methotrexate—colon cancer	0.00021	0.00108	CcSEcCtD
Boceprevir—Infestation—Methotrexate—colon cancer	0.000209	0.00107	CcSEcCtD
Boceprevir—Infestation NOS—Methotrexate—colon cancer	0.000209	0.00107	CcSEcCtD
Boceprevir—Depression—Methotrexate—colon cancer	0.000208	0.00107	CcSEcCtD
Boceprevir—CTSS—Extracellular matrix organization—CDH1—colon cancer	0.000208	0.00432	CbGpPWpGaD
Boceprevir—CTSK—Immune System—BCL10—colon cancer	0.000208	0.00431	CbGpPWpGaD
Boceprevir—ABCB1—lymph node—colon cancer	0.000207	0.00158	CbGeAlD
Boceprevir—Stevens-Johnson syndrome—Methotrexate—colon cancer	0.000207	0.00106	CcSEcCtD
Boceprevir—Vision blurred—Capecitabine—colon cancer	0.000207	0.00106	CcSEcCtD
Boceprevir—Stomatitis—Methotrexate—colon cancer	0.000204	0.00104	CcSEcCtD
Boceprevir—Ill-defined disorder—Capecitabine—colon cancer	0.000204	0.00104	CcSEcCtD
Boceprevir—Urticaria—Fluorouracil—colon cancer	0.000204	0.00104	CcSEcCtD
Boceprevir—Conjunctivitis—Methotrexate—colon cancer	0.000203	0.00104	CcSEcCtD
Boceprevir—Anaemia—Capecitabine—colon cancer	0.000203	0.00104	CcSEcCtD
Boceprevir—Body temperature increased—Fluorouracil—colon cancer	0.000203	0.00104	CcSEcCtD
Boceprevir—Hypersensitivity—Vincristine—colon cancer	0.000202	0.00104	CcSEcCtD
Boceprevir—CTSV—Innate Immune System—BCL2L1—colon cancer	0.000202	0.00419	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—BCL2L1—colon cancer	0.000202	0.00419	CbGpPWpGaD
Boceprevir—Malaise—Capecitabine—colon cancer	0.000198	0.00101	CcSEcCtD
Boceprevir—Hepatobiliary disease—Methotrexate—colon cancer	0.000198	0.00101	CcSEcCtD
Boceprevir—Epistaxis—Methotrexate—colon cancer	0.000197	0.00101	CcSEcCtD
Boceprevir—Vertigo—Capecitabine—colon cancer	0.000197	0.00101	CcSEcCtD
Boceprevir—Hypersensitivity—Irinotecan—colon cancer	0.000197	0.00101	CcSEcCtD
Boceprevir—Asthenia—Vincristine—colon cancer	0.000197	0.00101	CcSEcCtD
Boceprevir—Syncope—Capecitabine—colon cancer	0.000197	0.00101	CcSEcCtD
Boceprevir—Leukopenia—Capecitabine—colon cancer	0.000196	0.001	CcSEcCtD
Boceprevir—Agranulocytosis—Methotrexate—colon cancer	0.000195	0.000998	CcSEcCtD
Boceprevir—Palpitations—Capecitabine—colon cancer	0.000194	0.000992	CcSEcCtD
Boceprevir—CMA1—Signaling by SCF-KIT—AKT1—colon cancer	0.000194	0.00403	CbGpPWpGaD
Boceprevir—CTSK—Extracellular matrix organization—CASP3—colon cancer	0.000193	0.00401	CbGpPWpGaD
Boceprevir—Loss of consciousness—Capecitabine—colon cancer	0.000193	0.000986	CcSEcCtD
Boceprevir—CTSL—Innate Immune System—FGFR3—colon cancer	0.000193	0.00401	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—FGFR3—colon cancer	0.000193	0.00401	CbGpPWpGaD
Boceprevir—Asthenia—Irinotecan—colon cancer	0.000192	0.000982	CcSEcCtD
Boceprevir—Cough—Capecitabine—colon cancer	0.000192	0.000979	CcSEcCtD
Boceprevir—Hypertension—Capecitabine—colon cancer	0.000189	0.000969	CcSEcCtD
Boceprevir—Hypersensitivity—Fluorouracil—colon cancer	0.000189	0.000966	CcSEcCtD
Boceprevir—Diarrhoea—Vincristine—colon cancer	0.000188	0.000961	CcSEcCtD
Boceprevir—CTSK—Adaptive Immune System—CD8A—colon cancer	0.000188	0.0039	CbGpPWpGaD
Boceprevir—Chest pain—Capecitabine—colon cancer	0.000187	0.000955	CcSEcCtD
Boceprevir—Myalgia—Capecitabine—colon cancer	0.000187	0.000955	CcSEcCtD
Boceprevir—Arthralgia—Capecitabine—colon cancer	0.000187	0.000955	CcSEcCtD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—TOP1—colon cancer	0.000187	0.00388	CbGpPWpGaD
Boceprevir—Pharyngitis—Methotrexate—colon cancer	0.000186	0.000952	CcSEcCtD
Boceprevir—Anxiety—Capecitabine—colon cancer	0.000186	0.000952	CcSEcCtD
Boceprevir—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.000186	0.000949	CcSEcCtD
Boceprevir—Urinary tract disorder—Methotrexate—colon cancer	0.000185	0.000948	CcSEcCtD
Boceprevir—CTSV—Adaptive Immune System—FGFR3—colon cancer	0.000185	0.00385	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—FGFR3—colon cancer	0.000185	0.00385	CbGpPWpGaD
Boceprevir—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—colon cancer	0.000185	0.00385	CbGpPWpGaD
Boceprevir—Discomfort—Capecitabine—colon cancer	0.000185	0.000944	CcSEcCtD
Boceprevir—Urethral disorder—Methotrexate—colon cancer	0.000184	0.000941	CcSEcCtD
Boceprevir—Diarrhoea—Irinotecan—colon cancer	0.000183	0.000936	CcSEcCtD
Boceprevir—Dry mouth—Capecitabine—colon cancer	0.000183	0.000934	CcSEcCtD
Boceprevir—Dizziness—Vincristine—colon cancer	0.000182	0.000929	CcSEcCtD
Boceprevir—CTSV—Extracellular matrix organization—TGFB1—colon cancer	0.000182	0.00377	CbGpPWpGaD
Boceprevir—CTSL—Extracellular matrix organization—TGFB1—colon cancer	0.000182	0.00377	CbGpPWpGaD
Boceprevir—Pruritus—Fluorouracil—colon cancer	0.000181	0.000927	CcSEcCtD
Boceprevir—Visual impairment—Methotrexate—colon cancer	0.000181	0.000925	CcSEcCtD
Boceprevir—Confusional state—Capecitabine—colon cancer	0.000181	0.000923	CcSEcCtD
Boceprevir—Infection—Capecitabine—colon cancer	0.000178	0.00091	CcSEcCtD
Boceprevir—Erythema multiforme—Methotrexate—colon cancer	0.000177	0.000907	CcSEcCtD
Boceprevir—Dizziness—Irinotecan—colon cancer	0.000177	0.000905	CcSEcCtD
Boceprevir—Shock—Capecitabine—colon cancer	0.000176	0.000901	CcSEcCtD
Boceprevir—Nervous system disorder—Capecitabine—colon cancer	0.000176	0.000898	CcSEcCtD
Boceprevir—Eye disorder—Methotrexate—colon cancer	0.000175	0.000897	CcSEcCtD
Boceprevir—Diarrhoea—Fluorouracil—colon cancer	0.000175	0.000897	CcSEcCtD
Boceprevir—Thrombocytopenia—Capecitabine—colon cancer	0.000175	0.000897	CcSEcCtD
Boceprevir—Tinnitus—Methotrexate—colon cancer	0.000175	0.000895	CcSEcCtD
Boceprevir—Tachycardia—Capecitabine—colon cancer	0.000175	0.000894	CcSEcCtD
Boceprevir—Vomiting—Vincristine—colon cancer	0.000175	0.000893	CcSEcCtD
Boceprevir—Cardiac disorder—Methotrexate—colon cancer	0.000174	0.000891	CcSEcCtD
Boceprevir—Skin disorder—Capecitabine—colon cancer	0.000174	0.00089	CcSEcCtD
Boceprevir—Rash—Vincristine—colon cancer	0.000173	0.000886	CcSEcCtD
Boceprevir—Hyperhidrosis—Capecitabine—colon cancer	0.000173	0.000885	CcSEcCtD
Boceprevir—Dermatitis—Vincristine—colon cancer	0.000173	0.000885	CcSEcCtD
Boceprevir—Headache—Vincristine—colon cancer	0.000172	0.00088	CcSEcCtD
Boceprevir—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—colon cancer	0.000172	0.00357	CbGpPWpGaD
Boceprevir—CTSS—Immune System—BCL10—colon cancer	0.000171	0.00355	CbGpPWpGaD
Boceprevir—Angiopathy—Methotrexate—colon cancer	0.00017	0.000871	CcSEcCtD
Boceprevir—Vomiting—Irinotecan—colon cancer	0.00017	0.00087	CcSEcCtD
Boceprevir—Immune system disorder—Methotrexate—colon cancer	0.00017	0.000867	CcSEcCtD
Boceprevir—Dizziness—Fluorouracil—colon cancer	0.000169	0.000867	CcSEcCtD
Boceprevir—Mediastinal disorder—Methotrexate—colon cancer	0.000169	0.000865	CcSEcCtD
Boceprevir—CMA1—Extracellular matrix organization—TGFB1—colon cancer	0.000169	0.00351	CbGpPWpGaD
Boceprevir—Rash—Irinotecan—colon cancer	0.000169	0.000863	CcSEcCtD
Boceprevir—Dermatitis—Irinotecan—colon cancer	0.000169	0.000862	CcSEcCtD
Boceprevir—Chills—Methotrexate—colon cancer	0.000168	0.000861	CcSEcCtD
Boceprevir—Headache—Irinotecan—colon cancer	0.000168	0.000857	CcSEcCtD
Boceprevir—Hypotension—Capecitabine—colon cancer	0.000167	0.000856	CcSEcCtD
Boceprevir—CYP3A4—Metapathway biotransformation—CHST5—colon cancer	0.000167	0.00347	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—BCL2L1—colon cancer	0.000167	0.00347	CbGpPWpGaD
Boceprevir—Alopecia—Methotrexate—colon cancer	0.000166	0.000848	CcSEcCtD
Boceprevir—Mental disorder—Methotrexate—colon cancer	0.000164	0.000841	CcSEcCtD
Boceprevir—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—colon cancer	0.000164	0.00341	CbGpPWpGaD
Boceprevir—Malnutrition—Methotrexate—colon cancer	0.000163	0.000835	CcSEcCtD
Boceprevir—Erythema—Methotrexate—colon cancer	0.000163	0.000835	CcSEcCtD
Boceprevir—Nausea—Vincristine—colon cancer	0.000163	0.000835	CcSEcCtD
Boceprevir—Musculoskeletal discomfort—Capecitabine—colon cancer	0.000163	0.000834	CcSEcCtD
Boceprevir—Vomiting—Fluorouracil—colon cancer	0.000163	0.000833	CcSEcCtD
Boceprevir—Insomnia—Capecitabine—colon cancer	0.000162	0.000828	CcSEcCtD
Boceprevir—Rash—Fluorouracil—colon cancer	0.000162	0.000826	CcSEcCtD
Boceprevir—Dermatitis—Fluorouracil—colon cancer	0.000161	0.000826	CcSEcCtD
Boceprevir—Paraesthesia—Capecitabine—colon cancer	0.000161	0.000822	CcSEcCtD
Boceprevir—Headache—Fluorouracil—colon cancer	0.000161	0.000821	CcSEcCtD
Boceprevir—Dysgeusia—Methotrexate—colon cancer	0.00016	0.000818	CcSEcCtD
Boceprevir—CTSK—Innate Immune System—FGFR3—colon cancer	0.00016	0.00332	CbGpPWpGaD
Boceprevir—Dyspnoea—Capecitabine—colon cancer	0.00016	0.000816	CcSEcCtD
Boceprevir—CTSS—Extracellular matrix organization—CASP3—colon cancer	0.000159	0.00331	CbGpPWpGaD
Boceprevir—Nausea—Irinotecan—colon cancer	0.000159	0.000813	CcSEcCtD
Boceprevir—Back pain—Methotrexate—colon cancer	0.000158	0.000808	CcSEcCtD
Boceprevir—Dyspepsia—Capecitabine—colon cancer	0.000158	0.000806	CcSEcCtD
Boceprevir—CTSL—Adaptive Immune System—CDH1—colon cancer	0.000156	0.00325	CbGpPWpGaD
Boceprevir—CTSV—Adaptive Immune System—CDH1—colon cancer	0.000156	0.00325	CbGpPWpGaD
Boceprevir—Decreased appetite—Capecitabine—colon cancer	0.000156	0.000796	CcSEcCtD
Boceprevir—Gastrointestinal disorder—Capecitabine—colon cancer	0.000155	0.000791	CcSEcCtD
Boceprevir—CTSS—Adaptive Immune System—CD8A—colon cancer	0.000154	0.00321	CbGpPWpGaD
Boceprevir—Fatigue—Capecitabine—colon cancer	0.000154	0.00079	CcSEcCtD
Boceprevir—Vision blurred—Methotrexate—colon cancer	0.000154	0.000787	CcSEcCtD
Boceprevir—CTSK—Adaptive Immune System—FGFR3—colon cancer	0.000153	0.00319	CbGpPWpGaD
Boceprevir—Pain—Capecitabine—colon cancer	0.000153	0.000783	CcSEcCtD
Boceprevir—Constipation—Capecitabine—colon cancer	0.000153	0.000783	CcSEcCtD
Boceprevir—Nausea—Fluorouracil—colon cancer	0.000152	0.000778	CcSEcCtD
Boceprevir—Ill-defined disorder—Methotrexate—colon cancer	0.000152	0.000775	CcSEcCtD
Boceprevir—Anaemia—Methotrexate—colon cancer	0.000151	0.000772	CcSEcCtD
Boceprevir—CTSK—Extracellular matrix organization—TGFB1—colon cancer	0.00015	0.00313	CbGpPWpGaD
Boceprevir—Feeling abnormal—Capecitabine—colon cancer	0.000148	0.000755	CcSEcCtD
Boceprevir—Malaise—Methotrexate—colon cancer	0.000147	0.000753	CcSEcCtD
Boceprevir—Vertigo—Methotrexate—colon cancer	0.000147	0.000751	CcSEcCtD
Boceprevir—Gastrointestinal pain—Capecitabine—colon cancer	0.000146	0.000749	CcSEcCtD
Boceprevir—Leukopenia—Methotrexate—colon cancer	0.000146	0.000748	CcSEcCtD
Boceprevir—Cough—Methotrexate—colon cancer	0.000143	0.000729	CcSEcCtD
Boceprevir—Urticaria—Capecitabine—colon cancer	0.000142	0.000728	CcSEcCtD
Boceprevir—Body temperature increased—Capecitabine—colon cancer	0.000142	0.000724	CcSEcCtD
Boceprevir—Abdominal pain—Capecitabine—colon cancer	0.000142	0.000724	CcSEcCtD
Boceprevir—Myalgia—Methotrexate—colon cancer	0.000139	0.000711	CcSEcCtD
Boceprevir—Chest pain—Methotrexate—colon cancer	0.000139	0.000711	CcSEcCtD
Boceprevir—Arthralgia—Methotrexate—colon cancer	0.000139	0.000711	CcSEcCtD
Boceprevir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	0.000138	0.000706	CcSEcCtD
Boceprevir—CTSS—Innate Immune System—BCL2L1—colon cancer	0.000138	0.00286	CbGpPWpGaD
Boceprevir—Discomfort—Methotrexate—colon cancer	0.000137	0.000703	CcSEcCtD
Boceprevir—CTSV—Immune System—CD8A—colon cancer	0.000137	0.00285	CbGpPWpGaD
Boceprevir—CTSL—Immune System—CD8A—colon cancer	0.000137	0.00285	CbGpPWpGaD
Boceprevir—Confusional state—Methotrexate—colon cancer	0.000134	0.000687	CcSEcCtD
Boceprevir—Infection—Methotrexate—colon cancer	0.000132	0.000677	CcSEcCtD
Boceprevir—Hypersensitivity—Capecitabine—colon cancer	0.000132	0.000675	CcSEcCtD
Boceprevir—CTSS—Innate Immune System—FGFR3—colon cancer	0.000132	0.00273	CbGpPWpGaD
Boceprevir—Nervous system disorder—Methotrexate—colon cancer	0.000131	0.000669	CcSEcCtD
Boceprevir—Thrombocytopenia—Methotrexate—colon cancer	0.000131	0.000668	CcSEcCtD
Boceprevir—CTSK—Adaptive Immune System—CDH1—colon cancer	0.00013	0.00269	CbGpPWpGaD
Boceprevir—Skin disorder—Methotrexate—colon cancer	0.00013	0.000662	CcSEcCtD
Boceprevir—Hyperhidrosis—Methotrexate—colon cancer	0.000129	0.000659	CcSEcCtD
Boceprevir—Asthenia—Capecitabine—colon cancer	0.000129	0.000657	CcSEcCtD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—DCC—colon cancer	0.000127	0.00264	CbGpPWpGaD
Boceprevir—Pruritus—Capecitabine—colon cancer	0.000127	0.000648	CcSEcCtD
Boceprevir—CTSS—Adaptive Immune System—FGFR3—colon cancer	0.000126	0.00262	CbGpPWpGaD
Boceprevir—Hypotension—Methotrexate—colon cancer	0.000125	0.000637	CcSEcCtD
Boceprevir—CTSS—Extracellular matrix organization—TGFB1—colon cancer	0.000124	0.00257	CbGpPWpGaD
Boceprevir—Diarrhoea—Capecitabine—colon cancer	0.000123	0.000627	CcSEcCtD
Boceprevir—Musculoskeletal discomfort—Methotrexate—colon cancer	0.000121	0.000621	CcSEcCtD
Boceprevir—Insomnia—Methotrexate—colon cancer	0.000121	0.000617	CcSEcCtD
Boceprevir—CTSL—Innate Immune System—CTNNB1—colon cancer	0.00012	0.0025	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—CTNNB1—colon cancer	0.00012	0.0025	CbGpPWpGaD
Boceprevir—Paraesthesia—Methotrexate—colon cancer	0.00012	0.000612	CcSEcCtD
Boceprevir—Dyspnoea—Methotrexate—colon cancer	0.000119	0.000608	CcSEcCtD
Boceprevir—Dizziness—Capecitabine—colon cancer	0.000118	0.000606	CcSEcCtD
Boceprevir—CTSV—Innate Immune System—CDKN1A—colon cancer	0.000117	0.00244	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—CDKN1A—colon cancer	0.000117	0.00244	CbGpPWpGaD
Boceprevir—CTSV—Immune System—BCL2L1—colon cancer	0.000117	0.00244	CbGpPWpGaD
Boceprevir—CTSL—Immune System—BCL2L1—colon cancer	0.000117	0.00244	CbGpPWpGaD
Boceprevir—Dyspepsia—Methotrexate—colon cancer	0.000117	0.0006	CcSEcCtD
Boceprevir—Decreased appetite—Methotrexate—colon cancer	0.000116	0.000593	CcSEcCtD
Boceprevir—Gastrointestinal disorder—Methotrexate—colon cancer	0.000115	0.000589	CcSEcCtD
Boceprevir—Fatigue—Methotrexate—colon cancer	0.000115	0.000588	CcSEcCtD
Boceprevir—Pain—Methotrexate—colon cancer	0.000114	0.000583	CcSEcCtD
Boceprevir—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—colon cancer	0.000114	0.00237	CbGpPWpGaD
Boceprevir—Vomiting—Capecitabine—colon cancer	0.000114	0.000582	CcSEcCtD
Boceprevir—CTSK—Immune System—CD8A—colon cancer	0.000114	0.00236	CbGpPWpGaD
Boceprevir—Rash—Capecitabine—colon cancer	0.000113	0.000577	CcSEcCtD
Boceprevir—Dermatitis—Capecitabine—colon cancer	0.000113	0.000577	CcSEcCtD
Boceprevir—CTSV—Adaptive Immune System—CDKN1A—colon cancer	0.000113	0.00234	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—CDKN1A—colon cancer	0.000113	0.00234	CbGpPWpGaD
Boceprevir—CTSL—Immune System—FGFR3—colon cancer	0.000112	0.00233	CbGpPWpGaD
Boceprevir—CTSV—Immune System—FGFR3—colon cancer	0.000112	0.00233	CbGpPWpGaD
Boceprevir—Headache—Capecitabine—colon cancer	0.000112	0.000574	CcSEcCtD
Boceprevir—CTSL—Innate Immune System—EP300—colon cancer	0.000112	0.00232	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—EP300—colon cancer	0.000112	0.00232	CbGpPWpGaD
Boceprevir—Feeling abnormal—Methotrexate—colon cancer	0.00011	0.000562	CcSEcCtD
Boceprevir—Gastrointestinal pain—Methotrexate—colon cancer	0.000109	0.000557	CcSEcCtD
Boceprevir—CTSV—Innate Immune System—SRC—colon cancer	0.000109	0.00226	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—SRC—colon cancer	0.000109	0.00226	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—HNF4A—colon cancer	0.000107	0.00223	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—CDH1—colon cancer	0.000107	0.00222	CbGpPWpGaD
Boceprevir—Nausea—Capecitabine—colon cancer	0.000106	0.000544	CcSEcCtD
Boceprevir—Urticaria—Methotrexate—colon cancer	0.000106	0.000542	CcSEcCtD
Boceprevir—Abdominal pain—Methotrexate—colon cancer	0.000105	0.000539	CcSEcCtD
Boceprevir—Body temperature increased—Methotrexate—colon cancer	0.000105	0.000539	CcSEcCtD
Boceprevir—CTSV—Innate Immune System—NRAS—colon cancer	0.000105	0.00217	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—NRAS—colon cancer	0.000105	0.00217	CbGpPWpGaD
Boceprevir—CTSV—Adaptive Immune System—SRC—colon cancer	0.000104	0.00217	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—SRC—colon cancer	0.000104	0.00217	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—CA7—colon cancer	0.000103	0.00214	CbGpPWpGaD
Boceprevir—CTSV—Adaptive Immune System—NRAS—colon cancer	0.0001	0.00209	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—NRAS—colon cancer	0.0001	0.00209	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—CTNNB1—colon cancer	9.96e-05	0.00207	CbGpPWpGaD
Boceprevir—Hypersensitivity—Methotrexate—colon cancer	9.82e-05	0.000502	CcSEcCtD
Boceprevir—CMA1—Metabolism of proteins—CTNNB1—colon cancer	9.77e-05	0.00203	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—CDKN1A—colon cancer	9.73e-05	0.00202	CbGpPWpGaD
Boceprevir—CTSK—Immune System—BCL2L1—colon cancer	9.73e-05	0.00202	CbGpPWpGaD
Boceprevir—Asthenia—Methotrexate—colon cancer	9.57e-05	0.000489	CcSEcCtD
Boceprevir—CTSV—Innate Immune System—EGFR—colon cancer	9.53e-05	0.00198	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—EGFR—colon cancer	9.53e-05	0.00198	CbGpPWpGaD
Boceprevir—CTSV—Immune System—CDH1—colon cancer	9.49e-05	0.00197	CbGpPWpGaD
Boceprevir—CTSL—Immune System—CDH1—colon cancer	9.49e-05	0.00197	CbGpPWpGaD
Boceprevir—Pruritus—Methotrexate—colon cancer	9.43e-05	0.000482	CcSEcCtD
Boceprevir—CTSS—Immune System—CD8A—colon cancer	9.37e-05	0.00195	CbGpPWpGaD
Boceprevir—CTSK—Adaptive Immune System—CDKN1A—colon cancer	9.35e-05	0.00194	CbGpPWpGaD
Boceprevir—CTSK—Immune System—FGFR3—colon cancer	9.3e-05	0.00193	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—EP300—colon cancer	9.26e-05	0.00192	CbGpPWpGaD
Boceprevir—CTSV—Adaptive Immune System—EGFR—colon cancer	9.15e-05	0.0019	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—EGFR—colon cancer	9.15e-05	0.0019	CbGpPWpGaD
Boceprevir—Diarrhoea—Methotrexate—colon cancer	9.12e-05	0.000466	CcSEcCtD
Boceprevir—CTSK—Innate Immune System—SRC—colon cancer	9e-05	0.00187	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—KRAS—colon cancer	9e-05	0.00187	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—KRAS—colon cancer	9e-05	0.00187	CbGpPWpGaD
Boceprevir—Dizziness—Methotrexate—colon cancer	8.82e-05	0.000451	CcSEcCtD
Boceprevir—CTSK—Innate Immune System—NRAS—colon cancer	8.66e-05	0.0018	CbGpPWpGaD
Boceprevir—CTSK—Adaptive Immune System—SRC—colon cancer	8.65e-05	0.0018	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—KRAS—colon cancer	8.64e-05	0.0018	CbGpPWpGaD
Boceprevir—CTSV—Adaptive Immune System—KRAS—colon cancer	8.64e-05	0.0018	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—BUB1B—colon cancer	8.57e-05	0.00178	CbGpPWpGaD
Boceprevir—Vomiting—Methotrexate—colon cancer	8.48e-05	0.000433	CcSEcCtD
Boceprevir—Rash—Methotrexate—colon cancer	8.41e-05	0.00043	CcSEcCtD
Boceprevir—Dermatitis—Methotrexate—colon cancer	8.4e-05	0.000429	CcSEcCtD
Boceprevir—Headache—Methotrexate—colon cancer	8.35e-05	0.000427	CcSEcCtD
Boceprevir—CTSK—Adaptive Immune System—NRAS—colon cancer	8.32e-05	0.00173	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—PIK3CA—colon cancer	8.27e-05	0.00172	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—PIK3CA—colon cancer	8.27e-05	0.00172	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—CTNNB1—colon cancer	8.2e-05	0.0017	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—CDKN1A—colon cancer	8.01e-05	0.00167	CbGpPWpGaD
Boceprevir—CTSS—Immune System—BCL2L1—colon cancer	8.01e-05	0.00167	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—PIK3CA—colon cancer	7.94e-05	0.00165	CbGpPWpGaD
Boceprevir—CTSV—Adaptive Immune System—PIK3CA—colon cancer	7.94e-05	0.00165	CbGpPWpGaD
Boceprevir—Nausea—Methotrexate—colon cancer	7.92e-05	0.000405	CcSEcCtD
Boceprevir—CTSK—Innate Immune System—EGFR—colon cancer	7.89e-05	0.00164	CbGpPWpGaD
Boceprevir—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—colon cancer	7.88e-05	0.00164	CbGpPWpGaD
Boceprevir—CTSK—Immune System—CDH1—colon cancer	7.86e-05	0.00163	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—CA7—colon cancer	7.77e-05	0.00161	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—CDKN1A—colon cancer	7.7e-05	0.0016	CbGpPWpGaD
Boceprevir—CTSS—Immune System—FGFR3—colon cancer	7.66e-05	0.00159	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—HRAS—colon cancer	7.65e-05	0.00159	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—HRAS—colon cancer	7.65e-05	0.00159	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—EP300—colon cancer	7.63e-05	0.00158	CbGpPWpGaD
Boceprevir—CTSK—Adaptive Immune System—EGFR—colon cancer	7.58e-05	0.00157	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—KRAS—colon cancer	7.46e-05	0.00155	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—SRC—colon cancer	7.42e-05	0.00154	CbGpPWpGaD
Boceprevir—CTSV—Adaptive Immune System—HRAS—colon cancer	7.34e-05	0.00153	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—HRAS—colon cancer	7.34e-05	0.00153	CbGpPWpGaD
Boceprevir—CTSK—Adaptive Immune System—KRAS—colon cancer	7.16e-05	0.00149	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—NRAS—colon cancer	7.13e-05	0.00148	CbGpPWpGaD
Boceprevir—ABCB1—HIF-1-alpha transcription factor network—EP300—colon cancer	7.12e-05	0.00148	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—SRC—colon cancer	7.12e-05	0.00148	CbGpPWpGaD
Boceprevir—CTSV—Immune System—CTNNB1—colon cancer	7e-05	0.00146	CbGpPWpGaD
Boceprevir—CTSL—Immune System—CTNNB1—colon cancer	7e-05	0.00146	CbGpPWpGaD
Boceprevir—ABCB1—Allograft Rejection—CASP3—colon cancer	6.88e-05	0.00143	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—NRAS—colon cancer	6.85e-05	0.00142	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—PIK3CA—colon cancer	6.85e-05	0.00142	CbGpPWpGaD
Boceprevir—CTSV—Immune System—CDKN1A—colon cancer	6.84e-05	0.00142	CbGpPWpGaD
Boceprevir—CTSL—Immune System—CDKN1A—colon cancer	6.84e-05	0.00142	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—AKT1—colon cancer	6.75e-05	0.0014	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—AKT1—colon cancer	6.75e-05	0.0014	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—FGFR3—colon cancer	6.75e-05	0.0014	CbGpPWpGaD
Boceprevir—ABCB1—HIF-1-alpha transcription factor network—VEGFA—colon cancer	6.75e-05	0.0014	CbGpPWpGaD
Boceprevir—CTSK—Adaptive Immune System—PIK3CA—colon cancer	6.58e-05	0.00137	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—colon cancer	6.57e-05	0.00136	CbGpPWpGaD
Boceprevir—CTSL—Immune System—EP300—colon cancer	6.51e-05	0.00135	CbGpPWpGaD
Boceprevir—CTSV—Immune System—EP300—colon cancer	6.51e-05	0.00135	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—EGFR—colon cancer	6.5e-05	0.00135	CbGpPWpGaD
Boceprevir—CTSV—Adaptive Immune System—AKT1—colon cancer	6.48e-05	0.00135	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—AKT1—colon cancer	6.48e-05	0.00135	CbGpPWpGaD
Boceprevir—CTSS—Immune System—CDH1—colon cancer	6.47e-05	0.00134	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—HRAS—colon cancer	6.34e-05	0.00132	CbGpPWpGaD
Boceprevir—CTSV—Immune System—SRC—colon cancer	6.33e-05	0.00132	CbGpPWpGaD
Boceprevir—CTSL—Immune System—SRC—colon cancer	6.33e-05	0.00132	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—BAX—colon cancer	6.33e-05	0.00131	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—EGFR—colon cancer	6.24e-05	0.0013	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—ODC1—colon cancer	6.24e-05	0.0013	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—CHST5—colon cancer	6.24e-05	0.0013	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—APC—colon cancer	6.2e-05	0.00129	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—KRAS—colon cancer	6.14e-05	0.00128	CbGpPWpGaD
Boceprevir—CTSV—Immune System—NRAS—colon cancer	6.09e-05	0.00127	CbGpPWpGaD
Boceprevir—CTSL—Immune System—NRAS—colon cancer	6.09e-05	0.00127	CbGpPWpGaD
Boceprevir—CTSK—Adaptive Immune System—HRAS—colon cancer	6.09e-05	0.00126	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—KRAS—colon cancer	5.9e-05	0.00123	CbGpPWpGaD
Boceprevir—ABCB1—Allograft Rejection—VEGFA—colon cancer	5.84e-05	0.00121	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—BRAF—colon cancer	5.82e-05	0.00121	CbGpPWpGaD
Boceprevir—CTSK—Immune System—CTNNB1—colon cancer	5.8e-05	0.00121	CbGpPWpGaD
Boceprevir—CTSK—Immune System—CDKN1A—colon cancer	5.67e-05	0.00118	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—PIK3CA—colon cancer	5.64e-05	0.00117	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—AKT1—colon cancer	5.6e-05	0.00116	CbGpPWpGaD
Boceprevir—CTSV—Immune System—EGFR—colon cancer	5.55e-05	0.00115	CbGpPWpGaD
Boceprevir—CTSL—Immune System—EGFR—colon cancer	5.55e-05	0.00115	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—PIK3CA—colon cancer	5.42e-05	0.00113	CbGpPWpGaD
Boceprevir—CTSK—Immune System—EP300—colon cancer	5.39e-05	0.00112	CbGpPWpGaD
Boceprevir—CTSK—Adaptive Immune System—AKT1—colon cancer	5.37e-05	0.00112	CbGpPWpGaD
Boceprevir—ABCB1—Allograft Rejection—TGFB1—colon cancer	5.36e-05	0.00111	CbGpPWpGaD
Boceprevir—CTSK—Immune System—SRC—colon cancer	5.24e-05	0.00109	CbGpPWpGaD
Boceprevir—CTSV—Immune System—KRAS—colon cancer	5.24e-05	0.00109	CbGpPWpGaD
Boceprevir—CTSL—Immune System—KRAS—colon cancer	5.24e-05	0.00109	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—HRAS—colon cancer	5.22e-05	0.00108	CbGpPWpGaD
Boceprevir—CTSK—Immune System—NRAS—colon cancer	5.05e-05	0.00105	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—HRAS—colon cancer	5.01e-05	0.00104	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—APC—colon cancer	4.82e-05	0.001	CbGpPWpGaD
Boceprevir—CTSV—Immune System—PIK3CA—colon cancer	4.81e-05	0.001	CbGpPWpGaD
Boceprevir—CTSL—Immune System—PIK3CA—colon cancer	4.81e-05	0.001	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—CA7—colon cancer	4.79e-05	0.000994	CbGpPWpGaD
Boceprevir—CTSS—Immune System—CTNNB1—colon cancer	4.78e-05	0.000993	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—ODC1—colon cancer	4.71e-05	0.000978	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—CHST5—colon cancer	4.71e-05	0.000978	CbGpPWpGaD
Boceprevir—CTSS—Immune System—CDKN1A—colon cancer	4.67e-05	0.00097	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—AKT1—colon cancer	4.61e-05	0.000957	CbGpPWpGaD
Boceprevir—CTSK—Immune System—EGFR—colon cancer	4.6e-05	0.000955	CbGpPWpGaD
Boceprevir—CTSV—Immune System—HRAS—colon cancer	4.45e-05	0.000926	CbGpPWpGaD
Boceprevir—CTSL—Immune System—HRAS—colon cancer	4.45e-05	0.000926	CbGpPWpGaD
Boceprevir—CTSS—Immune System—EP300—colon cancer	4.44e-05	0.000923	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—AKT1—colon cancer	4.43e-05	0.000919	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—CASP3—colon cancer	4.37e-05	0.000907	CbGpPWpGaD
Boceprevir—CTSK—Immune System—KRAS—colon cancer	4.34e-05	0.000902	CbGpPWpGaD
Boceprevir—CTSS—Immune System—SRC—colon cancer	4.32e-05	0.000897	CbGpPWpGaD
Boceprevir—ABCB1—HIF-1-alpha transcription factor network—AKT1—colon cancer	4.3e-05	0.000894	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—CCND1—colon cancer	4.25e-05	0.000883	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—CTNNB1—colon cancer	4.21e-05	0.000875	CbGpPWpGaD
Boceprevir—CTSS—Immune System—NRAS—colon cancer	4.16e-05	0.000863	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—CDKN1A—colon cancer	4.11e-05	0.000854	CbGpPWpGaD
Boceprevir—CTSK—Immune System—PIK3CA—colon cancer	3.99e-05	0.000829	CbGpPWpGaD
Boceprevir—CTSV—Immune System—AKT1—colon cancer	3.93e-05	0.000817	CbGpPWpGaD
Boceprevir—CTSL—Immune System—AKT1—colon cancer	3.93e-05	0.000817	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—EP300—colon cancer	3.91e-05	0.000813	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—SRC—colon cancer	3.8e-05	0.00079	CbGpPWpGaD
Boceprevir—CTSS—Immune System—EGFR—colon cancer	3.79e-05	0.000787	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—VEGFA—colon cancer	3.71e-05	0.00077	CbGpPWpGaD
Boceprevir—CTSK—Immune System—HRAS—colon cancer	3.69e-05	0.000767	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—NRAS—colon cancer	3.66e-05	0.00076	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—colon cancer	3.66e-05	0.00076	CbGpPWpGaD
Boceprevir—CTSS—Immune System—KRAS—colon cancer	3.58e-05	0.000743	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—MYC—colon cancer	3.41e-05	0.000708	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—TGFB1—colon cancer	3.4e-05	0.000707	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—colon cancer	3.4e-05	0.000706	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—EGFR—colon cancer	3.33e-05	0.000693	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—colon cancer	3.31e-05	0.000687	CbGpPWpGaD
Boceprevir—CTSS—Immune System—PIK3CA—colon cancer	3.29e-05	0.000683	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—colon cancer	3.27e-05	0.00068	CbGpPWpGaD
Boceprevir—CTSK—Immune System—AKT1—colon cancer	3.26e-05	0.000677	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—colon cancer	3.2e-05	0.000665	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—KRAS—colon cancer	3.15e-05	0.000655	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—colon cancer	3.04e-05	0.000632	CbGpPWpGaD
Boceprevir—CTSS—Immune System—HRAS—colon cancer	3.04e-05	0.000632	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—colon cancer	2.96e-05	0.000615	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—CHST5—colon cancer	2.9e-05	0.000602	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—ODC1—colon cancer	2.9e-05	0.000602	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—PIK3CA—colon cancer	2.89e-05	0.000601	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—colon cancer	2.88e-05	0.000599	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—TP53—colon cancer	2.8e-05	0.000582	CbGpPWpGaD
Boceprevir—CTSS—Immune System—AKT1—colon cancer	2.68e-05	0.000558	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—HRAS—colon cancer	2.68e-05	0.000556	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—colon cancer	2.65e-05	0.000551	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—colon cancer	2.65e-05	0.00055	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—colon cancer	2.59e-05	0.000539	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—colon cancer	2.45e-05	0.000509	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—AKT1—colon cancer	2.36e-05	0.000491	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—colon cancer	2.25e-05	0.000468	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—colon cancer	2.18e-05	0.000453	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—colon cancer	1.84e-05	0.000382	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—ABCB1—colon cancer	1.65e-05	0.000342	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—TYMS—colon cancer	1.62e-05	0.000336	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—TYMS—colon cancer	1.22e-05	0.000254	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—PPARG—colon cancer	1.15e-05	0.000238	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—PTGS2—colon cancer	9.02e-06	0.000187	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—PPARG—colon cancer	8.65e-06	0.00018	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—ABCB1—colon cancer	7.66e-06	0.000159	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—TYMS—colon cancer	7.52e-06	0.000156	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—EP300—colon cancer	7.5e-06	0.000156	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—PTGS2—colon cancer	6.81e-06	0.000141	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—EP300—colon cancer	5.66e-06	0.000118	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—PIK3CA—colon cancer	5.55e-06	0.000115	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—PPARG—colon cancer	5.33e-06	0.000111	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—AKT1—colon cancer	4.53e-06	9.42e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—PTGS2—colon cancer	4.19e-06	8.71e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—PIK3CA—colon cancer	4.19e-06	8.7e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—EP300—colon cancer	3.49e-06	7.25e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—AKT1—colon cancer	3.42e-06	7.11e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—PIK3CA—colon cancer	2.58e-06	5.36e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—AKT1—colon cancer	2.11e-06	4.38e-05	CbGpPWpGaD
